Citigroup’s 89bio ETNB Stock Holding History

Citigroup’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$393K	–	6157
2025 Q2	$393K	Hold	40,000	–	–	﹤0.01%	3762
2025 Q1	$291K	Buy	+40,000	New	+$350K	﹤0.01%	3978
2024 Q2	–	Sell	-70,000	Closed	-$815K	–	5632
2024 Q1	$815K	Buy	+70,000	New	+$775K	﹤0.01%	3191

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup's ETNB Position: Q4 2025 in Review

Citigroup sold out of 89bio (ETNB) in Q4 2025, closing a stake of 144,436 shares — an estimated $2.12M sold.

Citigroup first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $6.86M in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Citigroup reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Citigroup sold 144,436 89bio shares in Q4 2025, an estimated $2.12M.
Citigroup first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
Citigroup's 89bio position peaked at $6.86M in Q4 2022.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.